The investment objective of this Sub-fund is to preserve capital and achieve long-term capital growth primarily by investing mainly throughout the biotechnology sector and in particular within the generic pharmaceuticals, large pharmaceuticals and specialty pharmaceuticals sub-sectors, across geographies and market capitalisations. North America, Nasdaq and small and mid-capitalized companies will be respectively the main geography, market and capitalisation focus of the Sub-Fund.
Fees and Expenses
Fund's portfolio distribution among the different geographical areas.
|United States of America||78,99%|
Fund's investments distribution.
|Editas Medicine Inc Ord||7,05%|
|Crispr Therapeutics Ag Ord||6,46%|
|Ardelyx Inc Ord||5,49%|
|Intuitive Surgical Inc Ord||4,79%|
|Arcutis Biotherapeutics Inc Ord||4,77%|
|Phathom Pharmaceuticals Inc Ord||4,72%|
|Personalis Inc Ord||4,72%|
|Nanostring Technologies Inc Ord||4,26%|
|Scpharmaceuticals Inc Ord||4,24%|
|89bio Inc Ord||4,21%|
Fund's possitions distribution by the sdctor they belong to.
|Non Classified Equity||0,31%|